Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and ...( SAN DIEGO May 27 /- Accumetrics Inc. ...)

SAN DIEGO, May 27 /PRNewswire/ -- Accumetrics, Inc. announces today it has signed new exclusive distribution agreements for its VerifyNow(R) System in several European countries. Distribution of Accumetrics' VerifyNow products will be handled by AAZ in France; BITmedical GmbH in both Austria and Switzerland; and Kordia in the Netherlands, Belgium and Luxembourg. The VerifyNow System assesses response to life-saving antiplatelet therapies, such as aspirin, Plavix(R) and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.

"We're extremely excited to continue with the global expansion of our distribution strategy for the VerifyNow System. Accumetrics has chosen each of these partners based on their demonstrated expertise and knowledge of our markets in their respective territories," said Timothy I. Still, President and CEO of the Company. "These partnerships demonstrate our ongoing expansion of our distribution channels outside the United States, and support our vision to provide physicians access to critical information for managing their cardiovascular patients on antiplatelet therapies."

About Accumetrics (www.accumetrics.com )

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-c
'/>"/>